Data on Life Science Reported by Researchers at Kobe Pharmaceutical University (Intravenous Administration of 90 Y-labeled Polyoxazoline Combined With Tumor Heating Potently Inhibits Tumor Growth In Mice).

Researchers at Kobe Pharmaceutical University in Japan have conducted a study on the intravenous administration of 90 Y-labeled Polyoxazoline combined with tumor heating to inhibit tumor growth in mice. The study focused on the cellular uptake of the labeled Polyoxazoline and its antitumor effects in combination with tumor heating. The results showed a potent therapeutic effect of the labeled Polyoxazoline in combination with tumor heating, indicating its potential for radionuclide therapy of tumors. The research was funded by various organizations and has been peer-reviewed, providing valuable insights into potential advancements in cancer therapy. [Extracted from the article]